$211 Million is the total value of AIGH Capital Management LLC's 96 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 45.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ANIP | Sell | ANI PHARMACEUTICALS INC | $15,838,826 | -16.0% | 272,801 | -22.1% | 7.50% | -2.6% |
TELA | Sell | TELA BIO INC | $10,023,560 | -40.3% | 1,252,945 | -24.4% | 4.74% | -30.8% |
AVNW | Sell | AVIAT NETWORKS INC | $9,907,373 | -40.7% | 317,544 | -36.6% | 4.69% | -31.2% |
BDSX | Sell | BIODESIX INC | $8,096,052 | +30.0% | 4,906,698 | -3.1% | 3.83% | +50.9% |
CLNN | Sell | CLENE INC | $2,877,151 | -44.9% | 5,801,878 | -2.3% | 1.36% | -36.1% |
Sell | COYA THERAPEUTICS INC | $2,061,469 | -13.7% | 535,794 | -8.7% | 0.98% | +0.1% | |
ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $1,985,977 | -15.8% | 1,323,985 | -10.8% | 0.94% | -2.4% |
Sell | CELLECTAR BIOSCIENCES INC | $1,788,630 | +12.8% | 677,511 | -16.7% | 0.85% | +30.9% | |
Sell | IDEAL PWR INC | $893,628 | -51.6% | 91,947 | -41.2% | 0.42% | -43.8% | |
ANVS | Sell | ANNOVIS BIO INC | $464,450 | -92.2% | 48,941 | -88.3% | 0.22% | -91.0% |
Sell | PROSOMNUS INC | $399,143 | -66.4% | 378,528 | -2.0% | 0.19% | -61.0% | |
VCNX | Exit | VACCINEX INC | $0 | – | -1,352,570 | -100.0% | -0.19% | – |
OSMT | Exit | RVL PHARMACEUTICALS PLC | $0 | – | -1,116,653 | -100.0% | -0.26% | – |
MTLS | Exit | MATERIALISE NVsponsored ads | $0 | – | -124,912 | -100.0% | -0.44% | – |
BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -708,235 | -100.0% | -0.60% | – |
Exit | SOLENO THERAPEUTICS INC | $0 | – | -364,306 | -100.0% | -0.64% | – | |
APPS | Exit | DIGITAL TURBINE INC | $0 | – | -171,680 | -100.0% | -0.65% | – |
THTX | Exit | THERATECHNOLOGIES INC | $0 | – | -3,404,710 | -100.0% | -1.17% | – |
CMBM | Exit | CAMBIUM NETWORKS CORP | $0 | – | -296,668 | -100.0% | -1.84% | – |
MCHP | Exit | MICROCHIP TECHNOLOGY INC. | $0 | – | -250,000 | -100.0% | -9.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
SCPHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
FRANKLIN WIRELESS CORP | 11 | Q3 2023 | 2.9% |
IDEAL PWR INC | 11 | Q3 2023 | 2.5% |
MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
LIGHTPATH TECHNOLOGIES INC | 10 | Q3 2023 | 3.0% |
MYOMO INC | 10 | Q3 2023 | 1.3% |
DZS INC | 9 | Q1 2023 | 7.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.